About this trial
The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate.
The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine.
Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Head and neck, hand, foot, or genital burns
On anticoagulants (except NSAIDs)
On monoamine oxidase inhibitor or tricyclic antidepressant
Coronary or peripheral vascular disease
Trial design
Parallel
Treatments tested in this trial
Phenylephrine
Drug
Treatment groups
Trial outcomes
Primary outcomes
Mean arterial blood pressure (MAP)
Mean arterial blood pressure
Secondary outcomes
Blood Pressure
Cut off for safety: Diastolic \>140 or Systolic \>180; Recorded: * just prior to induction of anesthesia * maximum heart rate during time of procedure * minimum heart rate during time of procedure
Heart Rate
Recorded: * just prior to induction of anesthesia * maximum heart rate during time of procedure * minimum heart rate during time of procedure
Sponsors and contacts
Click on the lead sponsor to view all of their trials.